Reimbursement Newsletter

RJ Health provides insight into new drugs and devices, code price updates and more as it applies to medically covered drugs.

Specialty Drug Reimbursement Newsletter | July 2025

July

15

2025

RJ Health, an MMIT company, delivers industry standard specialty drug pricing, coding and reimbursement solutions to support payer and provider alignment.

Every month, our team evaluates a variety of pricing and coding updates. In the July edition of the Specialty Drug Reimbursement Newsletter, we identified 113 drug code price changes this month, with 21 of them being price decreases. We have also identified drugs to be added or updated within our database. Preview some of these insights below:

This month, during our review of the 3926 Reimbursement HCPCS/CPT® Codes in our system, we identified 113 Drug Codes that required a recalculation of their AWP Code Price. Clients can log in to www.ReimbursementCodes.com to view the pricing updates for these codes.

86580 A9800 J0894 J3373 J9275 Q4378
90283 B4153 J1100 J3374 J9276 Q4379
90284 B4158 J1163 J3375 J9281 Q5098
90382 B4185 J1201 J3391 J9289 Q5099
90623 C9174 J1230 J7172 J9320 Q5100
90625 C9175 J1322 J7183 J9341 Q5113
90675 E0607 J1326 J7209 J9342 Q9968
90690 E2100 J1412 J7356 J9353 S0078
90691 J0133 J1458 J7613 J9382 S0108
90714 J0165 J1558 J7626 Q2058 S0119
90717 J0166 J1561 J8530 Q4247 S5010
A4215 J0167 J1956 J8560 Q4263 S5551
A4230 J0168 J2060 J9041 Q4268 S8490
A4253 J0169 J2278 J9174 Q4269
A4259 J0256 J2290 J9202 Q4300
A9513 J0567 J2312 J9214 Q4311
A9524 J0583 J2313 J9218 Q4312
A9584 J0616 J2543 J9220 Q4319
A9587 J0618 J2710 J9245 Q4321
A9607 J0702 J3110 J9264 Q4373

ReimbursementCodes was designed for organizations like yours to manage pricing, coding and clinical challenges related to specialty drugs. To gain access to this tool and view the rest of the insights we captured this month, visit our site or contact marketing@mmitnetwork.com.

Featured
Emerging-Treatments-Offer-New-Hope-Alcohol-Use-Disorder

Emerging Treatments Offer New Hope for Alcohol Use Disorder

Key-Takeaways-Rare-Disease-Commercialization

Competitive ATTR Dynamics: Key Takeaways for Rare-Disease Commercialization

Alternative-Funding-Programs

Alternative Funding Programs: Short-Term Savings, Long-Term Consequences

Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch